Find uplifting stories about heroes, innovations, and solutions
1379 results for "chronic lymphocytic leukemia"
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
A new targeted therapy for chronic myeloid leukemia achieved major molecular responses in nearly half of patients with advanced disease. The drug, ELVN-001, performed even better in patients treated earlier, offering fresh hope in the fight against this slow-growing blood cancer.
A groundbreaking five-year research program could help two-thirds of chronic myeloid leukemia patients stop treatment forever instead of taking daily medication for life. Scientists are now focused on understanding why some patients can safely quit therapy while others cannot.
A Buddhist meditation teacher who developed chronic illness from black mold exposure discovered how mindfulness and hypnosis can rewire the brain to help people suffering from ongoing health conditions. Her personal journey is now helping others find hope and healing.
Researchers at University of Chicago discovered why a mutation makes adult leukemia so resistant to treatment and identified a strategy that could extend survival by a year. The breakthrough could reshape how doctors treat one in 10 adult leukemia patients.
Scientists discovered a brain circuit that drives chronic pain separately from protective acute pain, opening the door to treatments that could help 60 million Americans without dulling their danger responses. When researchers silenced this circuit in mice, chronic pain disappeared while normal pain signals stayed intact.
For 50 million Americans living with chronic pain that drugs can't touch, Virginia Tech researchers just delivered groundbreaking news: they've reversed persistent pain in mice by targeting a previously overlooked biological pathway. The discovery could lead to the first new non-opioid chronic pain treatment in years.
Researchers at Memorial Sloan Kettering developed a groundbreaking CAR T cell therapy that targets leukemia while sparing healthy blood cells. The innovation came from studying patients whose cancer went into long-term remission.
Australian scientists are launching a five-year program to help more leukemia patients stop treatment permanently. Only one in three chronic myeloid leukemia patients can safely quit therapy today, but new research aims to change that.
Joe Slachciak, 18, is celebrating being cancer-free after spending his 17th birthday in the hospital fighting leukemia. His positive attitude and love of superheroes made him the perfect honorary survivor for Relay For Life's superhero-themed event.
When Britt Mayo was diagnosed with leukemia in 2010, one conversation about his life priorities helped him avoid chemotherapy and qualify for a trial that led to remission. Now he's helping other patients learn they have choices in their cancer care.
A small clinical trial reveals that ketamine, already used for depression, may offer rapid energy relief to millions suffering from chronic fatigue. The findings give hope to patients who've exhausted all other options.
Scientists discovered a protein that could help transform stubborn leukemia cells into healthy white blood cells that die naturally. The breakthrough could offer hope for patients with the most aggressive forms of blood cancer.
%252c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Scientists at MD Anderson Cancer Center discovered an experimental therapy that stops aggressive leukemia cells even after they've become resistant to standard treatments. The breakthrough could help patients with the deadliest forms of blood cancer who have run out of options.
Scientists discovered that intermittent fasting not only reduces chronic pain but also eases the anxiety and depression that often come with it. The breakthrough could lead to new treatments that tackle both problems at once.
Researchers at the University of Oslo have found a way to halt cancer stem cells in acute myeloid leukemia by targeting a molecule previously thought to worsen the disease. The breakthrough could lead to personalized treatments that stop cancer before it spreads.
A groundbreaking blood test can predict which leukemia patients are most likely to relapse after bone marrow transplants, helping doctors personalize treatment. The discovery could transform care for thousands battling this aggressive blood cancer.
Virginia Tech researchers have successfully reversed chronic pain in mice by blocking a single enzyme pathway, offering hope for 50 million Americans whose pain doesn't respond to current treatments. The breakthrough targets a biological mechanism previously overlooked by conventional painkillers.
Researchers have identified the genetic fingerprint of "sleeping" pain neurons that affect 10% of people with chronic nerve pain. This breakthrough opens the door to targeted treatments that could silence overactive pain signals without affecting normal sensation.
Researchers discovered a natural pain control switch in the brain that could lead to safer treatments for millions suffering from chronic nerve pain. The finding offers hope for relief without the risks of traditional opioid medications.
Showing 20 of 1379